Literature DB >> 33554637

Evaluation of Trueness and Precision of a Bench-Top Laboratory Glucose Analyzer Using Reference Materials.

Annette Baumstark1, Stefan Pleus1, Matthias Hartwig2, Guido Freckmann1.   

Abstract

SUPER GL compact is a bench-top analyzer for glucose, lactate, and hemoglobin concentrations. Glucose measurements in the biosensor are based on an enzymatic-amperometric reaction of glucose with glucose oxidase.In this study, trueness and precision were assessed with Standard Reference Material 965b (National Institute of Standards and Technology, Gaithersburg, MD) for 2 SUPER GL compact (S1 and S2) and 1 YSI 2300 STAT Plus (Y) device, using a protocol based on CLSI EP05-A3.Precision was similar among S1, S2, and Y. S1 and S2 exhibited negative bias at low concentrations and positive bias at high concentrations, whereas Y showed negative bias that increased with higher concentrations. Overall, SUPER GL compact's performance was comparable to that of YSI 2300 STAT Plus.

Entities:  

Keywords:  glucose analyzer; glucose oxidase; precision; trueness

Mesh:

Substances:

Year:  2021        PMID: 33554637      PMCID: PMC9294562          DOI: 10.1177/1932296821991216

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  4 in total

1.  System accuracy evaluation of systems for point-of-care testing of blood glucose: a comparison of a patient-use system with six professional-use systems.

Authors:  Guido Freckmann; Christina Schmid; Stefan Pleus; Annette Baumstark; Manuela Link; Erhard Stolberg; Cornelia Haug; Jochen Sieber
Journal:  Clin Chem Lab Med       Date:  2014-07       Impact factor: 3.694

2.  The YSI 2300 Analyzer Replacement Meeting Report.

Authors:  Julia Han; Lutz Heinemann; Barry H Ginsberg; Shridhara Alva; Matthias Appel; Stephan Bess; Kong Y Chen; Guido Freckmann; Dennis R Harris; Matthias Hartwig; Rolf Hinzmann; David Kerr; Jan Krouwer; Linda Morrow; James Nichols; Andreas Pfützner; Stefan Pleus; Mark Rice; David B Sacks; Kevin Schlueter; Hubert W Vesper; David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2020-03-16

3.  Approved IFCC recommendation on reporting results for blood glucose: International Federation of Clinical Chemistry and Laboratory Medicine Scientific Division, Working Group on Selective Electrodes and Point-of-Care Testing (IFCC-SD-WG-SEPOCT).

Authors:  Paul D'Orazio; Robert W Burnett; Niels Fogh-Andersen; Ellis Jacobs; Katsuhiko Kuwa; Wolf R Külpmann; Lasse Larsson; Andrzej Lewenstam; Anton H J Maas; Gerhard Mager; Jerzy W Naskalski; Anthony O Okorodudu
Journal:  Clin Chem Lab Med       Date:  2006       Impact factor: 3.694

4.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

  4 in total
  3 in total

1.  Do We Need the Replacement of YSI 2300? A View from the Clinical Laboratory.

Authors:  Loukia Spanou; Konstantinos Makris
Journal:  J Diabetes Sci Technol       Date:  2021-05-17

2.  Ultra rapid lispro (URLi) shows accelerated pharmacokinetics and greater reduction in postprandial glucose versus Humalog® in patients with type 1 diabetes mellitus in a randomized, double-blind meal test early-phase study.

Authors:  Christof Kazda; Jennifer Leohr; Rong Liu; Shobha Reddy; Mary Anne Dellva; Mei Teng Loh; Thomas Hardy; Leona Plum-Mörschel
Journal:  Diabetes Obes Metab       Date:  2021-10-24       Impact factor: 6.408

3.  Ultra-rapid lispro shows faster pharmacokinetics and reduces postprandial glucose excursions versus Humalog® in patients with type 2 diabetes mellitus in a randomized, controlled crossover meal test early phase study.

Authors:  Jennifer Leohr; Christof Kazda; Rong Liu; Shobha Reddy; Mary Anne Dellva; Mark Matzopoulos; Mei Teng Loh; Thomas Hardy; Oliver Klein; Christoph Kapitza
Journal:  Diabetes Obes Metab       Date:  2021-10-27       Impact factor: 6.408

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.